Cota Founder and Executive Chairman Honored with Dr. Sol J. Barer Award for Vision, Innovation and Leadership

NEW YORK, Feb. 6, 2018 /PRNewswire/ -- Cota Inc., a real-world data and analytics company bridging precision medicine to population health, announced that its founder, Andrew Pecora, M.D., was honored with the Dr. Sol J. Barer Award for Vision, Innovation and Leadership at BioNJ's 25^th Annual Gateway Gala & Innovation Celebration on February 1, 2018. The event, which took place at the Hilton East Brunswick, brought together more than 750 attendees from the biopharmaceutical industry to celebrate visionary leadership in the life sciences.

"Dr. Pecora has dedicated his career to being a true visionary and finding innovative ways to improve care for patients and the health system at large, including founding Cota with the mission to enable optimal clinical outcomes for every individual patient and reduce the total cost of care," said John Hervey, Cota chief executive officer. "He is the embodiment of the characteristics that the Dr. Sol J. Barer Award for Vision, Innovation and Leadership celebrates."

Cota, which was founded by Dr. Pecora in 2011, builds solutions for healthcare organizations that deliver precision medicine, enabling better decision-making with real-world data and cutting-edge clinical classification. The company's patented Cota Nodal Address™ (CNA) is the first and only system that precisely categorizes patient factors, their diseases and intended therapies. The CNA provides a way to easily evaluate and select the most cost-effective treatment for optimal patient outcomes, reducing unwarranted variation in cost and outcome.

"Cota has prospered and grown over the last few years due to Dr. Pecora's vision and leadership," said Andrew von Eschenbach, M.D., former director of the National Cancer Institute and member of Cota's board of directors. "We are thrilled to see him honored with the prestigious Dr. Sol J. Barer award, which is well-deserved."

In addition to serving as Cota's executive chairman, Dr. Pecora is the vice president of cancer services and chief innovation officer at Hackensack University Medical Center, and both founded and served as president of Regional Cancer Care Associates. Dr. Pecora is also a professor of medicine at University of Medicine and Dentistry of New Jersey (UMDNJ)–New Jersey Medical School, and a professor of oncology and medicine at Georgetown University.

"Dr. Pecora is a driving force in the industry and has made countless contributions to the growth and prosperity of the life sciences industry, both in the U.S. and abroad," added Donald Berwick, M.D., MPP, FRCP, Cota Board of Directors member. "He is on the forefront of applying precision medicine to oncology and revolutionizing the entire healthcare system."

To learn more about the innovative work that Dr. Pecora is leading at Cota, visit https://www.cotahealthcare.com/.

About Cota 
Cota is a real-world data and analytics company that enables providers, payers and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.

Cota's technology enriches medical records to create research-grade data and joins it with a suite of analysis, visualization and management tools. This enables providers, payers and life science companies to analyze, report on and research outcomes, costs, treatments and quality at any granularity and stage of the patient journey. The result is a constantly improving system that merges technology and medicine to improve the lives of patients everywhere. For more information, go to www.cotahealthcare.com 

Alessandra Nix
SHIFT Communications
[email protected]   
617.779.1860

SOURCE Cota Inc.